The content on this site is intended for healthcare professionals only
Dr Brian Leyland-Jones speaks to ecancer about the upcoming WIN symposium and his role as lead fundraiser.
He begins by outlining the high profile leaders of the WIN consortium, and why this has led to great successes throughout WIN's history.
Dr Leyland-Jones also describes why WIN focuses on the translational aspect of precision oncology, and what the challenges are involved in this.
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
ASCO 2024: Lung cancer highlights
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Choosing Wisely in radiology Tanzania
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Moving to the future: Artificial intelligence in surgery
Systemic anti-cancer performance matrix
